查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1657258

糖化血红素 (HbA1c) 检测市场：2034 年的机会与策略

Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 312 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2019 年全球糖化血红素 (HbA1c) 检测市值为 14.1048 亿美元，预计到 2024 年复合年增长率将超过 5.00%。

个人化医疗日益受到关注

对个人化医疗的日益关注推动了迄今为止的糖化血红蛋白 (HbA1c) 检测市场的成长。 HbA1c 测试提供两到三个月内血糖值的纵向视图，使医疗保健提供者能够优化糖尿病管理。透过整合药物基因组学，个人化医疗可以根据基因图谱定製药物选择和剂量。 HbA1c 结果可指导治疗调整併改善治疗效果。例如，根据美国个人化医疗联盟（PMC）的数据，美国组织代表科学家、患者和医疗保健提供者，旨在促进对个人化医疗的理解和广泛采用，造福患者和医疗保健系统。 截至2022年10月，市场上有超过75,000种基因检测产品和超过300种个人化药物，适用于一系列癌症、罕见遗传疾病以及一系列癌症、罕见遗传疾病和多种癌症和感染疾病患者。此外，到2022年，个人化药物将占美国食品药物管理局批准的新药认证的34%，而在过去八年中，个人化药物每年都占核准的25%以上。因此，对个人化医疗的日益关注推动了糖化血红蛋白 (HbA1c) 检测市场的成长。

目录

第一章执行摘要

  • 糖化血红蛋白 (HbA1c) 检测－市场吸引力和宏观经济条件

第 2 章 目录

第 3 章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 糖化血红蛋白 (HbA1c) 检测市场定义和细分
  • 市场区隔：按类型
    • 实验室测试
    • 照护现场（PoC）测试
  • 市场区隔：依产品类型
    • 试剂和套件
    • 装置
    • 软体和服务
  • 按技术细分的市场
    • 免疫检测
    • 层析法
    • 酵素测定
    • 硼酸亲和层析法
    • 高效液相层析
    • 其他技术
  • 市场区隔：按最终用户
    • 医院和诊所
    • 诊断实验室
    • 居家照护环境
    • 其他最终用户

第七章：主要市场趋势

  • 推出新一代照护现场设备，增强糖尿病管理和早期诊断
  • 使用家庭糖尿病风险 (HbA1c) 测量套件增强您的健康
  • 测试进展，重点在于高效液相层析(HPLC) 分析仪，以增强糖尿病管理
  • 使用经血进行月经血红蛋白 (HbA1c) 检测的创新

8. 糖化血红蛋白 (HbA1c) 检测市场：宏观经济情景

  • COVID-19 的影响：糖化血红蛋白 (HbA1c) 检测市场
  • 乌克兰战争的影响：糖化血红蛋白 (HbA1c) 检测市场
  • 高通膨的影响：糖化血红蛋白 (HbA1c) 检测市场

第九章 全球市场规模及成长

  • 市场规模
  • 2019 年至 2024 年市场成长表现
    • 市场驱动因素 2019-2024
    • 2019 至 2024 年市场限制
  • 2024-2029 年及 2034 年市场成长预测
    • 市场驱动因素 2024-2029
    • 市场限制 2024-2029

第 10 章 整体糖化血红素 (HbA1c) 测试量

  • 2019 年至 2024 年市场成长表现
  • 2024-2029 年及 2034 年市场成长预测

第 11 章。

  • 全球糖化血红蛋白 (HbA1c) 检测市场：按类型、性能和预测，2019-2024 年、2029 年、2034 年
  • 全球糖化血红蛋白 (HbA1c) 检测市场（按产品类型、性能和预测）2019-2024 年、2029 年、2034 年
  • 全球糖化血红蛋白 (HbA1c) 检测市场（按技术、性能和预测）2019-2024 年、2029 年预测、2034 年预测
  • 全球糖化血红蛋白 (HbA1c) 检测市场：免疫检测按产品类型、性能和预测，2019-2024 年、2029 年预测、2034 年预测
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按产品类型、性能和预测的酶测定法，2019-2024 年、2029 年预测、2034 年预测
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按最终用户、绩效和预测，2019-2024 年、2029 年预测、2034 年预测

第 12 章。

  • 全球糖化血红素 (HbA1c) 检测市场：按地区、绩效和预测，2019-2024 年、2029 年、2034 年
  • 全球糖化血红蛋白 (HbA1c) 检测市场：按国家/地区、绩效和预测，2019-2024 年、2029 年、2034 年

第十三章 亚太市场

第十四章 西欧市场

第十五章 东欧市场

第十六章 北美市场

第十七章 南美洲市场

第十八章 中东市场

第 19 章：非洲市场

第 20 章竞争格局与公司概况

  • 公司简介
  • Danaher Corporation（Beckman Coulter, Inc.）
  • F. Hoffman-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc

第21章 其他大型创新企业

  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Sysmex Corporation
  • ARKRAY Inc
  • Tosoh Corporation
  • Agappe Diagnostics Ltd
  • A. Menarini Diagnostics srl
  • EKF Diagnostics Holdings plc
  • SD Biosensor
  • Sekisui Diagnostics LLC
  • PTS Diagnostics
  • SEBIA
  • Trinity Biotech PLC
  • Osang Healthcare Co. Ltd
  • Diazyme Laboratories

第 22 章 竞争性基准化分析

第 23 章 竞争仪錶板

第24章 重大併购

  • Roche Holding AG Acquired LumiraDx To Enhance Primary Care Diagnostics
  • Tosoh Corporation Acquired Semba Biosciences Inc. To Enhance Biologics Purification and HbA1c Testing

第25章机会与策略

  • 2029 年全球糖化血红素 (HbA1c) 检测市场：提供新机会的国家
  • 2029 年全球糖化血红蛋白 (HbA1c) 检测市场：细分市场提供新机会
  • 2029 年全球糖化血红蛋白 (HbA1c) 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 26 章 糖化血红素 (HbA1c) 检测市场：结论与建议

  • 结论
  • 建议
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第 27 章 附录

简介目录
Product Code: o&s1503

Hemoglobin A1c (HbA1c) testing refers to the diagnostic and monitoring tools used to measure the average blood glucose levels over the past two to three months. The test is used to diagnose diabetes, prediabetes, and evaluate the effectiveness of treatment plans in people with diabetes. It is an essential component of diabetes management and is widely used by healthcare providers to assess how well diabetes is being controlled.

The HbA1C testing market consists of sales, by entities (organizations, sole traders and partnerships), of HbA1C testing that provides a reliable indication of blood sugar levels by quantifying the percentage of glycosylated hemoglobin in the blood, offering an essential parameter for long-term glucose monitoring. The testing is primarily used by endocrinologists, general practitioners and other healthcare professionals in hospitals, clinics and diagnostic laboratories. Patients themselves may also use these tests in homecare settings for self-monitoring purposes.

The global hemoglobin A1c (HbA1c) testing market was valued at $1,410.48 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 5.00%.

Increasing Focus On Personalized Medicine

The increasing focus on personalized medicine supported the growth of the hemoglobin A1c (HbA1c) testing market during the historic period. HbA1c testing offers a long-term view of blood glucose levels over 2-3 months, enabling healthcare providers to optimize diabetes management. By integrating pharmacogenomics, personalized medicine adjusts drug selection and dosing based on genetic profiles. HbA1c results guide therapy modifications, enhancing treatment efficacy. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, more than 75,000 genetic testing products and 300 personalized medicines were present on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, in 2022, personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increasing focus on personalized medicine drove the growth of the hemoglobin A1c (HbA1c) testing market.

Advancements In Testing With Focus on High-Performance Liquid Chromatography (HPLC) Analyzers for Enhanced Diabetes Management

Leading companies in the hemoglobin A1c (HbA1c) testing market are concentrating on creating innovative solutions, including high-performance liquid chromatography (HPLC) analyzers, to enhance the accuracy, speed, and efficiency of diabetes management. HPLC analyzers are utilized to accurately measure the percentage of HbA1c in blood samples, delivering precise data for the diagnosis and ongoing monitoring of diabetes. For instance, in June 2021, Trivitron Healthcare, an India-based medical device company, launched two innovative high-performance liquid chromatography (HPLC) analyzers, the NANO H5 and NANO H110, designed for the rapid detection of glycated hemoglobin (HbA1c) and hemoglobin variants. These analyzers aim to enhance diabetes management and thalassemia diagnostics by providing results in under three minutes. The NANO H5 is a compact, fully automated HPLC analyzer that utilizes ion exchange liquid chromatography for the quantitative determination of glycated hemoglobin (HbA1c) in whole human blood. Like the NANO H5, the NANO H110 is also a compact and automated HPLC analyzer but features a dual test mode that allows for both HbA1c testing and Hb variant detection.

The global hemoglobin A1c (HbA1c) testing market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 18.1% of the total market in 2023.

Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hemoglobin A1c (HbA1c) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for hemoglobin A1c (HbA1c) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hemoglobin A1c (HbA1c) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider hemoglobin A1c (HbA1c) testing market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by product type, by technology and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the hemoglobin A1c (HbA1c) testing market.
  • Global Market Size And Growth Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by product type, by technology and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for hemoglobin A1c (HbA1c) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
  • 2) By Product Type: Reagents And Kits; Instruments; Software And Services
  • 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
  • Companies Mentioned: Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Abbott Laboratories; Bio-Rad Laboratories, Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Thailand; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hemoglobin A1c (HbA1c) testing indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Hemoglobin A1c (HbA1c) Testing - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Hemoglobin A1c (HbA1c) Testing Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Laboratory Based Testing
    • 6.4.2 Point Of Care (PoC) Testing
  • 6.5 Market Segmentation By Product Type
    • 6.5.1 Reagents And Kits
    • 6.5.2 Instruments
    • 6.5.3 Software And Services
  • 6.6 Market Segmentation By Technology
    • 6.6.1 Immunoassays
    • 6.6.2 Chromatography
    • 6.6.3 Enzymatic Assays
    • 6.6.4 Boronate Affinity Chromatography
    • 6.6.5 High Performance Liquid Chromatography
    • 6.6.6 Other Technologies
  • 6.7 Market Segmentation By End User
    • 6.7.1 Hospitals And Clinics
    • 6.7.2 Diagnostic Laboratories
    • 6.7.3 Homecare Settings
    • 6.7.4 Other End Users

7 Major Market Trends

  • 7.1 Launch Of Next-Generation Point-Of-Care Device Enhances Diabetes Management And Early Diagnosis
  • 7.2 Empowering Health With At-Home Diabetes Risk (HbA1c) Collection Kits
  • 7.3 Advancements In Testing With Focus on High-Performance Liquid Chromatography (HPLC) Analyzers for Enhanced Diabetes Management
  • 7.4 Innovations In Hemoglobin A1c (HbA1c) Testing Using Menstrual Blood

8 Hemoglobin A1c (HbA1c) Testing Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Hemoglobin A1c (HbA1c) Testing Market
  • 8.2 Impact Of The War In Ukraine On The Hemoglobin A1c (HbA1c) Testing Market
  • 8.3 Impact Of High Inflation On The Hemoglobin A1c (HbA1c) Testing Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 9.2.1 Market Drivers 2019 - 2024
    • 9.2.2 Market Restraints 2019 - 2024
  • 9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
    • 9.3.1 Market Drivers 2024 - 2029
    • 9.3.2 Market Restraints 2024 - 2029

10 Global Hemoglobin A1c (HbA1c) Testing Volume

  • 10.1 Historic Market Growth, 2019 - 2024, Volume (Million Units)
  • 10.2 Forecast Market Growth, 2024 - 2029, 2034F, Volume (Million Units)

11 Global Hemoglobin A1c (HbA1c) Testing Market Segmentation

  • 11.1 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.2 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.3 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Global Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Hemoglobin A1c (HbA1c) Testing Market, Regional and Country Analysis

  • 12.1 Global Hemoglobin A1c (HbA1c) Testing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.2 Global Hemoglobin A1c (HbA1c) Testing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Asia-Pacific Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.7 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Asia-Pacific Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
  • 13.9 Thailand Market
  • 13.10 Summary
  • 13.11 Market Overview
    • 13.11.1 Country Information
    • 13.11.2 Market Information
    • 13.11.3 Background Information
    • 13.11.4 Government Initiatives
    • 13.11.5 Regulations
    • 13.11.6 Regulatory Bodies
    • 13.11.7 Major Associations
    • 13.11.8 Taxes Levied
    • 13.11.9 Corporate Tax Structure
    • 13.11.10 Investments
    • 13.11.11 Major Companies
  • 13.12 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.13 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.14 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.15 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.16 Thailand Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.17 China Market
  • 13.18 Summary
  • 13.19 Market Overview
    • 13.19.1 Country Information
    • 13.19.2 Market Information
    • 13.19.3 Background Information
    • 13.19.4 Government Initiatives
    • 13.19.5 Regulations
    • 13.19.6 Regulatory Bodies
    • 13.19.7 Major Associations
    • 13.19.8 Taxes Levied
    • 13.19.9 Corporate Tax Structure
    • 13.19.10 Investments
    • 13.19.11 Major Companies
  • 13.20 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.21 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.22 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.23 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.24 China Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.25 India Market
  • 13.26 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.27 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.28 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.29 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.30 India Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.31 Japan Market
  • 13.32 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.33 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.34 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.35 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.36 Japan Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.37 Australia Market
  • 13.38 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.39 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.40 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.41 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.42 Australia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.43 Indonesia Market
  • 13.44 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.45 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.46 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.47 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.48 Indonesia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.49 South Korea Market
  • 13.50 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.51 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.52 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.53 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.54 South Korea Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Western Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate tax structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.7 Western Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.8 Western Europe Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
  • 14.9 UK Market
  • 14.10 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.14 UK Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.15 Germany Market
  • 14.16 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.19 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.20 Germany Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.21 France Market
  • 14.22 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.23 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.24 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.25 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.26 France Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.27 Italy Market
  • 14.28 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.29 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.30 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.31 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.32 Italy Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.33 Spain Market
  • 14.34 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.35 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.36 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.37 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.38 Spain Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 Eastern Europe Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.7 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Eastern Europe Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
  • 15.9 Russia Market
  • 15.10 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.11 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.12 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.13 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.14 Russia Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 North America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.6 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.7 North America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.8 North America Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
  • 16.9 USA Market
  • 16.10 Summary
  • 16.11 Market Overview
    • 16.11.1 Country Information
    • 16.11.2 Market Information
    • 16.11.3 Background Information
    • 16.11.4 Government Initiatives
    • 16.11.5 Regulations
    • 16.11.6 Regulatory Bodies
    • 16.11.7 Major Associations
    • 16.11.8 Taxes Levied
    • 16.11.9 Corporate Tax Structure
    • 16.11.10 Investments
    • 16.11.11 Major Companies
  • 16.12 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.13 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.14 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.15 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.16 USA Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.17 Canada Market
  • 16.18 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.19 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.20 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.21 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.22 Canada Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 South America Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.6 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.7 South America Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.8 South America Hemoglobin A1c (HbA1c) Testing Market: Country Analysis
  • 17.9 Brazil Market
  • 17.10 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.11 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.12 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.13 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.14 Brazil Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Middle East Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.4 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.5 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.6 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 18.7 Middle East Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Africa Market

  • 19.1 Summary
  • 19.2 Market Overview
    • 19.2.1 Region Information
    • 19.2.2 Market Information
    • 19.2.3 Background Information
    • 19.2.4 Government Initiatives
    • 19.2.5 Regulations
    • 19.2.6 Regulatory Bodies
    • 19.2.7 Major Associations
    • 19.2.8 Taxes Levied
    • 19.2.9 Corporate Tax Structure
    • 19.2.10 Investments
    • 19.2.11 Major Companies
  • 19.3 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 19.4 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 19.5 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Immunoassays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 19.6 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By Product Type For Enzymatic Assays, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 19.7 Africa Hemoglobin A1c (HbA1c) Testing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

20 Competitive Landscape And Company Profiles

  • 20.1 Company Profiles
  • 20.2 Danaher Corporation (Beckman Coulter, Inc.)
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
    • 20.2.3 Financial Overview
  • 20.3 F. Hoffman-La Roche Ltd
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
    • 20.3.3 Business Strategy
    • 20.3.4 Financial Overview
  • 20.4 Siemens Healthineers AG
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
    • 20.4.3 Business Strategy
    • 20.4.4 Financial Overview
  • 20.5 Abbott Laboratories
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
    • 20.5.3 Business Strategy
    • 20.5.4 Financial Overview
  • 20.6 Bio-Rad Laboratories, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
    • 20.6.3 Financial Overview

21 Other Major And Innovative Companies

  • 21.1 Randox Laboratories Ltd
    • 21.1.1 Company Overview
    • 21.1.2 Products and Services
  • 21.2 Thermo Fisher Scientific Inc
    • 21.2.1 Company Overview
    • 21.2.2 Products and Services
  • 21.3 Sysmex Corporation
    • 21.3.1 Company Overview
    • 21.3.2 Products and Services
  • 21.4 ARKRAY Inc
    • 21.4.1 Company Overview
    • 21.4.2 Products and Services
  • 21.5 Tosoh Corporation
    • 21.5.1 Company Overview
    • 21.5.2 Products and Services
  • 21.6 Agappe Diagnostics Ltd
    • 21.6.1 Company Overview
    • 21.6.2 Products and Services
  • 21.7 A. Menarini Diagnostics srl
    • 21.7.1 Company Overview
    • 21.7.2 Products and Services
  • 21.8 EKF Diagnostics Holdings plc
    • 21.8.1 Company Overview
    • 21.8.2 Products and Services
  • 21.9 SD Biosensor
    • 21.9.1 Company Overview
    • 21.9.2 Products and Services
  • 21.10 Sekisui Diagnostics LLC
    • 21.10.1 Company Overview
    • 21.10.2 Products and Services
  • 21.11 PTS Diagnostics
    • 21.11.1 Company Overview
    • 21.11.2 Products and Services
  • 21.12 SEBIA
    • 21.12.1 Company Overview
    • 21.12.2 Products and Services
  • 21.13 Trinity Biotech PLC
    • 21.13.1 Company Overview
    • 21.13.2 Products and Services
  • 21.14 Osang Healthcare Co. Ltd
    • 21.14.1 Company Overview
    • 21.14.2 Products and Services
  • 21.15 Diazyme Laboratories
    • 21.15.1 Company Overview
    • 21.15.2 Products and Services

22 Competitive Benchmarking

23 Competitive Dashboard

24 Key Mergers And Acquisitions

  • 24.1 Roche Holding AG Acquired LumiraDx To Enhance Primary Care Diagnostics
  • 24.2 Tosoh Corporation Acquired Semba Biosciences Inc. To Enhance Biologics Purification and HbA1c Testing

25 Opportunities And Strategies

  • 25.1 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 25.2 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 25.3 Global Hemoglobin A1c (HbA1c) Testing Market In 2029 - Growth Strategies
    • 25.3.1 Market Trend Based Strategies
    • 25.3.2 Competitor Strategies

26 Hemoglobin A1c (HbA1c) Testing Market, Conclusions And Recommendations

  • 26.1 Conclusions
  • 26.2 Recommendations
    • 26.2.1 Product
    • 26.2.2 Place
    • 26.2.3 Price
    • 26.2.4 Promotion
    • 26.2.5 People

27 Appendix

  • 27.1 Geographies Covered
  • 27.2 Market Data Sources
  • 27.3 Research Methodology
  • 27.4 Currencies
  • 27.5 The Business Research Company
  • 27.6 Copyright and Disclaimer